Skip to Main Content

Author Details

Teodora Goranova
CRUK Cambridge Institute, University of Cambridge
2009
26
14
PMIDPaper TitleJournal TitlePublished Year
37474499The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37752102Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37875466Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.Nat Commun2023
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33570999FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.JCO Clin Cancer Inform2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32073954Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial.J Clin Oncol2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
30404863Enhanced detection of circulating tumor DNA by fragment size analysis.Sci Transl Med2018
30104763Copy number signatures and mutational processes in ovarian carcinoma.Nat Genet2018
28881617Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility gene.Oncotarget2017
28359078Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.Br J Cancer2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
27075652Strong Correlation Between mRNA Expression Levels of HIF-2α, VEGFR1, VEGFR2 and MMP2 in Laryngeal Carcinoma.Pathol Oncol Res2016
26681675Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.Ann Oncol2016
25149524Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.Pathol Oncol Res2015
26377995Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements.Biochem Genet2015
26824913Macrophageal infiltration and microvessel density in laryngeal carcinoma: study of 52 cases.Acta Otorhinolaryngol Ital2015
26137164Relative quantitative expression of hypoxia-inducible factor-1α, -2α and -3α, and vascular endothelial growth factor A in laryngeal carcinoma.Oncol Lett2015
25893891Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.Mol Diagn Ther2015
25563364Changes in gene expression of CXCR4, CCR7 and BCL2 after treatment of breast cancer cells with saponin extract from Tribulus terrestris.Neoplasma2015
23804521Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.Head Neck2014
24868540IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.Biomed Res Int2014
21380628Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors.Clin Exp Metastasis2011
20110242Clinical utility of the 70-gene MammaPrint profile in a Japanese population.Jpn J Clin Oncol2010
19079650Putative precursor cancer cells in human colorectal cancer tissue.Int J Clin Exp Pathol2009
  • 1 - 26 of 26

Recommended Authors

Chen Wang
College of Life Sciences, Sichuan University
Career Start Year 2013
Number of shared co-authors 5
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 11
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 3
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 2
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 44
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 5
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 2
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 28
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 5
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 5
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 1
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 5
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 7
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 4
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 3
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Gerrit A Meijer
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 53
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 27
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 7
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 91
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 8
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 15
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 3

Collaborators

Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 13
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 12
Iain A McNeish
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 9
Darren Ennis
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 8
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 8
Liz-Anne Lewsley
CRUK Clinical Trials Unit, University of Glasgow
Co-authored papers 6
Rosalind Glasspool
University of Glasgow
Co-authored papers 5
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 5
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 5
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 5
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 5
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 5
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 5
Honglin Song
University of Cambridge
Co-authored papers 5
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 4
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Dilrini De Silva
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 4
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 4
Matthew D Eldridge
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 4
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 4
Stacey J Winham
Mayo Clinic
Co-authored papers 4
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 4
Anna DeFazio
Westmead Hospital
Co-authored papers 4
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 4
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
Jennifer Alsop
University of Cambridge
Co-authored papers 4
Holly R Harris
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 4
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 4
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 4
Release 1.2